OrbiMed’s PepGen PEPG Stock Holding History

OrbiMed’s Portfolio PEPG Stock Details PEPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-653,016	Closed	-$2.47M	–	123
2024 Q4	$2.47M	Sell	653,016 -144,342	-18%	-$900K	0.05%	99
2024 Q3	$6.82M	Buy	+797,358	New	+$9.43M	0.12%	87

Other funds holding PEPG

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

OrbiMed's PEPG Position: Q1 2025 in Review

OrbiMed sold out of PepGen (PEPG) in Q1 2025, closing a stake of 653,016 shares — an estimated $2.47M sold.

OrbiMed first reported a position in PEPG in Q3 2024 and held it in 2 quarters. The position peaked at $6.82M in Q3 2024. 72 funds tracked by Wall St. Rank hold PEPG as of Q1 2025.

OrbiMed reported no remaining PepGen position as of Q1 2025 after selling out during the quarter.
OrbiMed sold 653,016 PepGen shares in Q1 2025, an estimated $2.47M.
OrbiMed first reported a position in PepGen in Q3 2024 and held it in 2 quarters.
OrbiMed's PepGen position peaked at $6.82M in Q3 2024.
72 funds tracked by Wall St. Rank held PepGen as of Q1 2025.

Based on OrbiMed's 13F filing for Q1 2025, filed 15 May 2025.